Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Disease    crawled date : 2021 - 11 - 04    save search

Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
GRPH 4 | $3.27 1.84% 490K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.38% H: 2.12% C: -3.71%

presentation disease phase 1 trial
Novartis iptacopan meets primary endpoints in Phase II study in rare kidney disease C3 glomerulopathy (C3G)
Published: 2021-11-04 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: -0.89%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.28% C: 0.18%

disease kidney rare
Sangamo Therapeutics Announces Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Patients With Fabry Disease
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M twitter stocktwits trandingview |
Health Technology
| | O: 7.39% H: 0.0% C: 0.0%

disease phase 1
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases
Published: 2021-11-04 (Crawled : 12:15) - biospace.com/
ATHE | $2.04 -4.67% -4.9% 54K twitter stocktwits trandingview |
Health Technology
| | O: 1.61% H: 5.56% C: 0.0%

disease neurodegenerative potential ath434
CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases
Published: 2021-11-04 (Crawled : 11:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K twitter stocktwits trandingview |
Commercial Services
| | O: 2.94% H: 1.83% C: -0.92%
AGIO | $29.52 0.31% 0.3% 750K twitter stocktwits trandingview |
Health Technology
| | O: 6.36% H: 1.98% C: -7.64%

disease partnership blood rare
GHIT Fund Announces New Investments: A Total of 750 Million Yen in Drugs for Malaria and Chagas Disease, Vaccine for Malaria, and Diagnostics for Tuberculosis
Published: 2021-11-04 (Crawled : 05:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.91% C: 0.77%

disease vaccine drug diagnostics diagnostic malaria
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.